{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:54:25Z","timestamp":1787507665681,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The project for the Osaka City Innovation Support Grant"},{"name":"Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS).","award":["20H03842"],"award-info":[{"award-number":["20H03842"]}]},{"name":"Fusion Oriented Research for Disruptive Science and Technology from Japan Science and Technology Agency","award":["JPMJFR210W"],"award-info":[{"award-number":["JPMJFR210W"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dry eye syndrome (DES) is a chronic ocular disease that induces epithelial damage to the cornea by decreasing tear production and quality. Adequate treatment options have not been established for severe DES such as Sjogren\u2019s syndrome due to complicated pathological conditions. To solve this problem, we focused on the conditioned medium of human adipose-derived mesenchymal stem cells (hAdMSC-CM), which have multiple therapeutic properties. Here, we showed that hAdMSC-CM suppressed Benzalkonium Chloride (BAC)-induced cytotoxicity and inflammation in human corneal epithelial cells (hCECs). In addition, hAdMSC-CM increased the expression level and regulated the localisation of barrier function-related components, and improved the BAC-induced barrier dysfunction in hCECs. RNA-seq analysis and pharmacological inhibition experiments revealed that the effects of hAdMSC-CM were associated with the TGF\u03b2 and JAK-STAT signalling pathways. Moreover, in DES model rats with exorbital and intraorbital lacrimal gland excision, ocular instillation of hAdMSC-CM suppressed corneal epithelial damage by improving barrier dysfunction of the cornea. Thus, we demonstrated that hAdMSC-CM has multiple therapeutic properties associated with TGF\u03b2 and JAK-STAT signalling pathways, and ocular instillation of hAdMSC-CM may serve as an innovative therapeutic agent for DES by improving corneal barrier function.<\/jats:p>","DOI":"10.1038\/s41598-023-40136-2","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T13:01:36Z","timestamp":1691758896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Ocular instillation of conditioned medium from mesenchymal stem cells is effective for dry eye syndrome by improving corneal barrier function"],"prefix":"10.1038","volume":"13","author":[{"given":"Tsutomu","family":"Imaizumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuhei","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaito","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Honma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"40136_CR1","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00003226-200009000-00009","volume":"19","author":"SC Pflugfelder","year":"2000","unstructured":"Pflugfelder, S. C., Solomon, A. & Stern, M. E. The diagnosis and management of dry eye. Cornea 19, 644\u2013649 (2000).","journal-title":"Cornea"},{"key":"40136_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/781683","author":"A Sharma","year":"2014","unstructured":"Sharma, A. & Hindman, H. B. Aging: A predisposition to dry eyes. J. Ophthalmol. https:\/\/doi.org\/10.1155\/2014\/781683 (2014).","journal-title":"J. Ophthalmol."},{"key":"40136_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-016-0148-x","volume":"14","author":"KC Shih","year":"2017","unstructured":"Shih, K. C., Lun, C. N., Jhanji, V., Thong, B. Y. H. & Tong, L. Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome. J. Inflamm. (Lond.) 14, 1\u201311 (2017).","journal-title":"J. Inflamm. (Lond.)"},{"key":"40136_CR4","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","volume":"124","author":"SC Pflugfelder","year":"2017","unstructured":"Pflugfelder, S. C. & de Paiva, C. S. The pathophysiology of dry eye disease: What we know and future directions for research. Ophthalmology 124, S4 (2017).","journal-title":"Ophthalmology"},{"key":"40136_CR5","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/ijms18071398","volume":"18","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. Dry eye management: Targeting the ocular surface microenvironment. Int. J. Mol. Sci. 18, 1398 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"40136_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BSR20150025","volume":"35","author":"I Ullah","year":"2015","unstructured":"Ullah, I., Subbarao, R. B. & Rho, G. J. Human mesenchymal stem cells - current trends and future prospective. Biosci. Rep. 35, 191 (2015).","journal-title":"Biosci. Rep."},{"key":"40136_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-014-0260-8","volume":"12","author":"M Madrigal","year":"2014","unstructured":"Madrigal, M., Rao, K. S. & Riordan, N. H. A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J. Transl. Med. 12, 1\u201314 (2014).","journal-title":"J. Transl. Med."},{"key":"40136_CR8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3727\/096368915X689622","volume":"25","author":"T Squillaro","year":"2016","unstructured":"Squillaro, T., Peluso, G. & Galderisi, U. Clinical trials with mesenchymal stem cells: An update. Cell Transp. 25, 829\u2013848 (2016).","journal-title":"Cell Transp."},{"key":"40136_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/461718","author":"H Orbay","year":"2012","unstructured":"Orbay, H., Tobita, M. & Mizuno, H. Mesenchymal stem cells isolated from adipose and other tissues: Basic biological properties and clinical applications. Stem Cells Int. https:\/\/doi.org\/10.1155\/2012\/461718 (2012).","journal-title":"Stem Cells Int."},{"key":"40136_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12917-021-03100-8","volume":"17","author":"U Rashid","year":"2021","unstructured":"Rashid, U. et al. Characterization and differentiation potential of mesenchymal stem cells isolated from multiple canine adipose tissue sources. BMC Vet. Res. 17, 1\u201312 (2021).","journal-title":"BMC Vet. Res."},{"key":"40136_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12886-015-0138-4","volume":"15","author":"L Zhang","year":"2015","unstructured":"Zhang, L., Coulson-Thomas, V. J., Ferreira, T. G. & Kao, W. W. Y. Mesenchymal stem cells for treating ocular surface diseases. BMC Ophthalmol. 15, 155 (2015).","journal-title":"BMC Ophthalmol."},{"key":"40136_CR12","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1002\/jcp.29486","volume":"235","author":"A Joseph","year":"2020","unstructured":"Joseph, A. et al. Mesenchymal stem cell-conditioned media: A novel alternative of stem cell therapy for quality wound healing. J. Cell Physiol. 235, 5555\u20135569 (2020).","journal-title":"J. Cell Physiol."},{"key":"40136_CR13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yclnex.2019.01.002","volume":"24","author":"R Noverina","year":"2019","unstructured":"Noverina, R. et al. Growth factors profile in conditioned medium human adipose tissue-derived mesenchymal stem cells (CM-hATMSCs). Clin. Nutr. Exp. 24, 34\u201344 (2019).","journal-title":"Clin. Nutr. Exp."},{"key":"40136_CR14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.reth.2019.06.005","volume":"11","author":"S Shibata","year":"2019","unstructured":"Shibata, S. et al. The secretome of adipose-derived mesenchymal stem cells attenuates epithelial\u2013mesenchymal transition in human corneal epithelium. Regen. Ther. 11, 114 (2019).","journal-title":"Regen. Ther."},{"key":"40136_CR15","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1167\/iovs.18-24803","volume":"59","author":"R Samaeekia","year":"2018","unstructured":"Samaeekia, R. et al. Effect of human corneal mesenchymal stromal cell-derived exosomes on corneal epithelial wound healing. Invest. Ophthalmol. Vis. Sci. 59, 5194 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40136_CR16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000519458","volume":"65","author":"G Wang","year":"2022","unstructured":"Wang, G. et al. Exosomes derived from mouse adipose-derived mesenchymal stem cells alleviate benzalkonium chloride-induced mouse dry eye model via inhibiting NLRP3 inflammasome. Ophthalmic Res. 65, 40\u201351 (2022).","journal-title":"Ophthalmic Res."},{"key":"40136_CR17","doi-asserted-by":"crossref","first-page":"14521","DOI":"10.1038\/s41598-020-71337-8","volume":"10","author":"C Yu","year":"2020","unstructured":"Yu, C. et al. hADSCs derived extracellular vesicles inhibit NLRP3inflammasome activation and dry eye. Sci. Rep. 10, 14521 (2020).","journal-title":"Sci. Rep."},{"key":"40136_CR18","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.4049\/jimmunol.1500610","volume":"195","author":"Y Gao","year":"2015","unstructured":"Gao, Y. et al. Female-specific down-regulation of tissue-PMN drives impaired Treg and amplified effector T cell responses in autoimmune dry eye disease. J. Immunol. 195, 3086 (2015).","journal-title":"J. Immunol."},{"key":"40136_CR19","first-page":"1","volume":"22","author":"W Huang","year":"2021","unstructured":"Huang, W., Tourmouzis, K., Perry, H., Honkanen, R. A. & Rigas, B. Animal models of dry eye disease: Useful, varied and evolving (Review). Exp. Ther. Med. 22, 1\u201310 (2021).","journal-title":"Exp. Ther. Med."},{"key":"40136_CR20","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/s41598-018-19578-6","volume":"8","author":"K Shinomiya","year":"2018","unstructured":"Shinomiya, K., Ueta, M. & Kinoshita, S. A new dry eye mouse model produced by exorbital and intraorbital lacrimal gland excision. Sci. Rep. 8, 1483 (2018).","journal-title":"Sci. Rep."},{"key":"40136_CR21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41433-021-01668-x","volume":"36","author":"MH Goldstein","year":"2022","unstructured":"Goldstein, M. H., Silva, F. Q., Blender, N., Tran, T. & Vantipalli, S. Ocular benzalkonium chloride exposure: Problems and solutions. Eye 36, 361 (2022).","journal-title":"Eye"},{"key":"40136_CR22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1089\/jop.2014.0030","volume":"30","author":"A Guzman-Aranguez","year":"2014","unstructured":"Guzman-Aranguez, A., Calvo, P., Ropero, I. & Pintor, J. In Vitro effects of preserved and unpreserved anti-allergic drugs on human corneal epithelial cells. J. Ocul. Pharmacol. Ther. 30, 790 (2014).","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"40136_CR23","doi-asserted-by":"crossref","first-page":"e40893","DOI":"10.1371\/journal.pone.0040893","volume":"7","author":"W Chen","year":"2012","unstructured":"Chen, W. et al. Localization and expression of zonula occludins-1 in the rabbit corneal epithelium following exposure to benzalkonium chloride. PLoS One 7, e40893 (2012).","journal-title":"PLoS One"},{"key":"40136_CR24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1442-9071.2004.00782.x","volume":"32","author":"SH Cha","year":"2004","unstructured":"Cha, S. H., Lee, J. S., Oum, B. S. & Kim, C. D. Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro. Clin. Exp. Ophthalmol. 32, 180\u2013184 (2004).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"40136_CR25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","volume":"26","author":"KC Yoon","year":"2007","unstructured":"Yoon, K. C., Jeong, I. Y., Park, Y. G. & Yang, S. Y. Interleukin-6 and tumor necrosis factor-\u03b1 levels in tears of patients with dry eye syndrome. Cornea 26, 431\u2013437 (2007).","journal-title":"Cornea"},{"key":"40136_CR26","first-page":"2283","volume":"42","author":"A Solomon","year":"2001","unstructured":"Solomon, A. et al. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest. Ophthalmol. Vis. Sci. 42, 2283 (2001).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40136_CR27","doi-asserted-by":"crossref","first-page":"108523","DOI":"10.1016\/j.exer.2021.108523","volume":"205","author":"A Shoari","year":"2021","unstructured":"Shoari, A., Kanavi, M. R. & Rasaee, M. J. Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome; A review study. Exp. Eye Res. 205, 108523 (2021).","journal-title":"Exp. Eye Res."},{"key":"40136_CR28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4137\/OED.S16067","volume":"6","author":"C Schultz","year":"2014","unstructured":"Schultz, C. Safety and efficacy of cyclosporine in the treatment of chronic dry eye. Ophthalmol. Eye Dis. 6, 37 (2014).","journal-title":"Ophthalmol. Eye Dis."},{"key":"40136_CR29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/exer.1996.0175","volume":"64","author":"SP Sugrue","year":"1997","unstructured":"Sugrue, S. P. & Zieske, J. D. ZO1 in corneal epithelium: Association to the zonula occludens and adherens junctions. Exp. Eye Res. 64, 11\u201320 (1997).","journal-title":"Exp. Eye Res."},{"key":"40136_CR30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/ACI.0b013e3283645899","volume":"13","author":"F Mantelli","year":"2013","unstructured":"Mantelli, F., Mauris, J. & Arg\u00fceso, P. The ocular surface epithelial barrier and other mechanisms of mucosal protection: From allergy to infectious diseases. Curr. Opin. Allergy Clin. Immunol. 13, 563\u2013568 (2013).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"40136_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/567305","author":"X Tian","year":"2011","unstructured":"Tian, X. et al. E-Cadherin\/\u03b2-catenin complex and the epithelial barrier. J. Biomed. Biotechnol. https:\/\/doi.org\/10.1155\/2011\/567305 (2011).","journal-title":"J. Biomed. Biotechnol."},{"key":"40136_CR32","doi-asserted-by":"crossref","first-page":"107724","DOI":"10.1016\/j.exer.2019.107724","volume":"186","author":"C Portal","year":"2019","unstructured":"Portal, C., Gouyer, V., Gottrand, F. & Desseyn, J. L. Ocular mucins in dry eye disease. Exp. Eye Res. 186, 107724 (2019).","journal-title":"Exp. Eye Res."},{"key":"40136_CR33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00535-017-1350-1","volume":"52","author":"S Ihara","year":"2017","unstructured":"Ihara, S., Hirata, Y. & Koike, K. TGF-\u03b2 in inflammatory bowel disease: A key regulator of immune cells, epithelium, and the intestinal microbiota. J. Gastroenterol. 52, 777\u2013787 (2017).","journal-title":"J. Gastroenterol."},{"key":"40136_CR34","first-page":"e24137","volume":"2","author":"L Bao","year":"2013","unstructured":"Bao, L., Zhang, H. & Chan, L. S. The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis. JAKSTAT 2, e24137 (2013).","journal-title":"JAKSTAT"},{"key":"40136_CR35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.alit.2021.10.004","volume":"71","author":"C Nakashima","year":"2022","unstructured":"Nakashima, C., Yanagihara, S. & Otsuka, A. Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors. Allergol. Int. 71, 40\u201346 (2022).","journal-title":"Allergol. Int."},{"key":"40136_CR36","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/ph14090840","volume":"14","author":"H Lei","year":"2021","unstructured":"Lei, H., Crawford, M. S. & McCole, D. F. JAK-STAT pathway regulation of intestinal permeability: Pathogenic roles and therapeutic opportunities in inflammatory bowel disease. Pharmaceuticals 14, 840 (2021).","journal-title":"Pharmaceuticals"},{"key":"40136_CR37","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/onc.2012.171","volume":"32","author":"C Freudlsperger","year":"2013","unstructured":"Freudlsperger, C. et al. TGF-\u03b2 and NF-\u03baB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene 32, 1549 (2013).","journal-title":"Oncogene"},{"key":"40136_CR38","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.4049\/jimmunol.146.10.3437","volume":"146","author":"JA Elias","year":"1991","unstructured":"Elias, J. A., Lentz, V. & Cummings, P. J. Transforming growth factor-beta regulation of IL-6 production by unstimulated and IL-1-stimulated human fibroblasts. J. Immunol. 146, 3437\u20133443 (1991).","journal-title":"J. Immunol."},{"key":"40136_CR39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1742-2094-7-88","volume":"7","author":"HL Hsieh","year":"2010","unstructured":"Hsieh, H. L., Wang, H. H., Bin Wu, W., Chu, P. J. & Yang, C. M. Transforming growth factor-\u03b21 induces matrix metalloproteinase-9 and cell migration in astrocytes: Roles of ROS-dependent ERK- and JNK-NF-\u03baB pathways. J. Neuroinflamm. 7, 88 (2010).","journal-title":"J. Neuroinflamm."},{"key":"40136_CR40","first-page":"2337","volume":"8","author":"ZY Li","year":"2016","unstructured":"Li, Z. Y., Chen, Z. L., Zhang, T., Wei, C. & Shi, W. Y. TGF-\u03b2 and NF-\u03baB signaling pathway crosstalk potentiates corneal epithelial senescence through an RNA stress response. Aging (Albany NY) 8, 2337 (2016).","journal-title":"Aging (Albany NY)"},{"key":"40136_CR41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu, J., Lamouille, S. & Derynck, R. TGF-\u03b2-induced epithelial to mesenchymal transition. Cell Res. 19, 156 (2009).","journal-title":"Cell Res."},{"key":"40136_CR42","doi-asserted-by":"crossref","first-page":"112823","DOI":"10.1016\/j.yexcr.2021.112823","volume":"407","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Green, C. R. & Mugisho, O. O. Cell transdifferentiation in ocular disease: Potential role for connexin channels. Exp. Cell Res. 407, 112823 (2021).","journal-title":"Exp. Cell Res."},{"key":"40136_CR43","first-page":"34","volume":"64","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. IFN-\u03b3 facilitates corneal epithelial cell pyroptosis through the JAK2\/STAT1 pathway in dry eye. Invest. Ophthalmol. Vis. Sci. 64, 34 (2023).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40136_CR44","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1167\/iovs.19-26928","volume":"60","author":"M Qu","year":"2019","unstructured":"Qu, M. et al. Therapeutic effects of STAT3 inhibition on experimental murine dry eye. Invest. Ophthalmol. Vis. Sci. 60, 3776\u20133785 (2019).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40136_CR45","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/OPX.0000000000000417","volume":"91","author":"X Cui","year":"2014","unstructured":"Cui, X. et al. Assessment of corneal epithelial thickness in dry eye patients. Optom. Vis. Sci. 91, 1446 (2014).","journal-title":"Optom. Vis. Sci."},{"key":"40136_CR46","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3390\/nu8110750","volume":"8","author":"CS Kim","year":"2016","unstructured":"Kim, C. S., Jo, K., Lee, I. S. & Kim, J. Topical application of apricot kernel extract improves dry eye symptoms in a unilateral exorbital lacrimal gland excision mouse. Nutrients 8, 750 (2016).","journal-title":"Nutrients"},{"key":"40136_CR47","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature17000","volume":"531","author":"R Hayashi","year":"2016","unstructured":"Hayashi, R. et al. Co-ordinated ocular development from human iPS cells and recovery of corneal function. Nature 531, 376\u2013380 (2016).","journal-title":"Nature"},{"key":"40136_CR48","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41586-022-04613-4","volume":"605","author":"R Hayashi","year":"2022","unstructured":"Hayashi, R. et al. Generation of 3D lacrimal gland organoids from human pluripotent stem cells. Nature 605, 126\u2013131 (2022).","journal-title":"Nature"},{"key":"40136_CR49","doi-asserted-by":"crossref","first-page":"108715","DOI":"10.1016\/j.celrep.2021.108715","volume":"34","author":"K Nomi","year":"2021","unstructured":"Nomi, K. et al. Generation of functional conjunctival epithelium, including goblet cells, from human iPSCs. Cell Rep 34, 108715 (2021).","journal-title":"Cell Rep"},{"key":"40136_CR50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1634\/stemcells.2006-0167","volume":"25","author":"R Hayashi","year":"2007","unstructured":"Hayashi, R. et al. N-cadherin is expressed by putative stem\/progenitor cells and melanocytes in the human limbal epithelial stem cell niche. Stem Cells 25, 289\u2013296 (2007).","journal-title":"Stem Cells"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40136-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40136-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40136-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T18:09:36Z","timestamp":1700590176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40136-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40136"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-40136-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2711893\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T. Imaizumi., Y.K., K.Y., S.S., T.O., T. Ishii., and Y.H. are employees of ROHTO Pharmaceutical Co., Ltd. R.H. is affiliated with the endowed chair of ROHTO Pharmaceutical Co., Ltd. K.N. and X.L. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13100"}}